Trials / Completed
CompletedNCT02328404
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
The Effect of Vitamin D Supplementation on Chromium Serum Levels and Insulin Resistance Among Overweight Jordanian Women With Polycystic Ovary Syndrome in Irbid
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hayat Pharmaceutical Co. PLC · Industry
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective double-blind, randomized, parallel-group, placebo-controlled trial designed to examine the effect of supplementation with 50,000 IU vitamin D3 for 3 months on Polycystic Ovary Syndrome (PCOS) prognosis, serum 25-Hydroxy Vitamin D (25(OH)D) level, serum chromium level, insulin resistance, and Body Mass Index (BMI), in 60 overweight Jordanian female patients diagnosed with PCOS and with hypovitaminosis D.
Detailed description
This study is designed to assess the safety and efficacy of 50,000 IU vitamin D supplementation once weekly for 3 months on improvement in PCOS prognosis and improvement in serum 25(OH)D levels in 60 overweight Jordanian females (defined as having a BMI 25-30kg/m2), diagnosed with PCOS (based on Rotterdam criteria), and with hypovitaminosis D (defined as a serum 25(OH)D level \< 20 ng/mL), compared with placebo. Evaluation of the safety and efficacy of the dosing regimen will be conducted over 6 study visits during which clinical and biochemical signs of PCOS as well as serum 25(OH)D level, serum chromium level, insulin resistance, and BMI will be evaluated. The measurements will be collected as follows : day (-7) during screening , Day (0) base line measurements , Day (30) , Day(60), Day (90), day (104).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 50,000 IU vitamin D3 | Film-coated tablet Biodal 50,000 IU containing cholecalciferol 50,000 IU |
| DRUG | Placebo | Placebo film-coated tablet of Biodal 50,000 IU |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-09-01
- Completion
- 2014-12-01
- First posted
- 2014-12-31
- Last updated
- 2016-08-04
- Results posted
- 2015-04-17
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT02328404. Inclusion in this directory is not an endorsement.